QingSong Health (HKG:2661) said the stabilization period for its global offering ended on Jan. 17, with no stabilizing action taken and the overallotment option lapsing unexercised, according to a Sunday Hong Kong bourse filing.

The company said there was no over-allocation in the international offering and no shares were issued under the over-allotment option.

QingSong Health added that it continues to comply with Hong Kong listing rules on public float, with at least 25% of its issued shares held by the public.